Skip to main navigation Skip to search Skip to main content

An Open Label Study of Topical Resiquimod (R-848) 0.01% Gel Applied 2 Times per Week for Each Recurrence of Herpes Genitalis over 52 Weeks

Project: Research

Project Details

StatusFinished
Effective start/end date12/1/02 → 10/9/04

Funding

  • 3M Pharmaceuticals: $1,890.00